NO852981L - Tricykliske dihydropyridazinoner og fremstilling derav. - Google Patents
Tricykliske dihydropyridazinoner og fremstilling derav.Info
- Publication number
- NO852981L NO852981L NO852981A NO852981A NO852981L NO 852981 L NO852981 L NO 852981L NO 852981 A NO852981 A NO 852981A NO 852981 A NO852981 A NO 852981A NO 852981 L NO852981 L NO 852981L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- acid
- compound
- hydrogen
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
- C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08419253A GB2164643B (en) | 1984-07-27 | 1984-07-27 | Tricyclic dihydropyridazinones and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO852981L true NO852981L (no) | 1986-01-28 |
Family
ID=10564580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO852981A NO852981L (no) | 1984-07-27 | 1985-07-26 | Tricykliske dihydropyridazinoner og fremstilling derav. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4692447A (instruction) |
| EP (1) | EP0169443A3 (instruction) |
| JP (1) | JPS6147468A (instruction) |
| KR (1) | KR880000728B1 (instruction) |
| CN (1) | CN85107017A (instruction) |
| AU (1) | AU576253B2 (instruction) |
| DD (1) | DD238972A5 (instruction) |
| DK (1) | DK327685A (instruction) |
| ES (1) | ES8609274A1 (instruction) |
| FI (1) | FI852699L (instruction) |
| GB (1) | GB2164643B (instruction) |
| GR (1) | GR851722B (instruction) |
| HU (1) | HU195193B (instruction) |
| IL (1) | IL75864A (instruction) |
| NO (1) | NO852981L (instruction) |
| NZ (1) | NZ212721A (instruction) |
| PT (1) | PT80854B (instruction) |
| ZA (1) | ZA855430B (instruction) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2164643B (en) * | 1984-07-27 | 1988-11-02 | Boehringer Biochemia Srl | Tricyclic dihydropyridazinones and pharmaceutical compositions containing them |
| JPH06763B2 (ja) * | 1984-08-28 | 1994-01-05 | 吉富製薬株式会社 | ベンゾ〔ｈ〕シンノリン誘導体 |
| AU578496B2 (en) * | 1984-11-01 | 1988-10-27 | Smith Kline & French Laboratories Limited | Tricyclic heterocyclic compounds |
| US4861773A (en) * | 1986-04-28 | 1989-08-29 | Smith Kline & French Laboratories Limited | Heterocyclic compounds |
| EP0281045B1 (en) * | 1987-03-02 | 1991-12-27 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzothiepino (5,4-c) pyridazine compounds and their pharmaceutical uses |
| WO1989004306A1 (fr) * | 1987-11-02 | 1989-05-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Composes de pyridazine fusionnes et leurs utilisations medicales |
| JP2717687B2 (ja) * | 1988-02-13 | 1998-02-18 | 日本曹達株式会社 | ピリダジノン誘導体及びその製造方法 |
| US5153194A (en) * | 1988-09-21 | 1992-10-06 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienocycloheptapyridazine compounds and their pharmaceutical use |
| FR2692895A1 (fr) * | 1992-06-26 | 1993-12-31 | Adir | Nouveaux 1-oxo 2,4,5,6-tétrahydro 2,3,7-triazaphénalènes leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US6448269B1 (en) | 1993-07-22 | 2002-09-10 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US6137002A (en) * | 1993-07-22 | 2000-10-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| IL110172A (en) * | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicyclic compounds and pharmaceutical compositions containing them |
| US8304415B2 (en) | 2010-02-25 | 2012-11-06 | National Defense Medical Center | 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof |
| US20160347034A1 (en) * | 2014-02-06 | 2016-12-01 | Basf Se | Insulating assembly for a storage vessel and process for its preparation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670043C3 (de) * | 1966-01-07 | 1975-05-22 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von 3-(Aminophenyl)-pyridazon-(6)-derivaten |
| US3464988A (en) * | 1968-01-11 | 1969-09-02 | Bristol Myers Co | 3-hydrazinobenzo(h)cinnolines and 3 - hydrazinobenzocyclohepta-(5,6-c)pyridazines |
| US4602019A (en) * | 1983-04-22 | 1986-07-22 | Warner-Lambert Company | Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents |
| GB2164643B (en) * | 1984-07-27 | 1988-11-02 | Boehringer Biochemia Srl | Tricyclic dihydropyridazinones and pharmaceutical compositions containing them |
-
1984
- 1984-07-27 GB GB08419253A patent/GB2164643B/en not_active Expired
-
1985
- 1985-07-08 FI FI852699A patent/FI852699L/fi not_active Application Discontinuation
- 1985-07-10 HU HU852670A patent/HU195193B/hu not_active IP Right Cessation
- 1985-07-10 EP EP85108605A patent/EP0169443A3/en not_active Withdrawn
- 1985-07-11 NZ NZ212721A patent/NZ212721A/xx unknown
- 1985-07-11 GR GR851722A patent/GR851722B/el unknown
- 1985-07-11 AU AU44814/85A patent/AU576253B2/en not_active Ceased
- 1985-07-18 ZA ZA855430A patent/ZA855430B/xx unknown
- 1985-07-18 DK DK327685A patent/DK327685A/da unknown
- 1985-07-22 IL IL75864A patent/IL75864A/xx not_active IP Right Cessation
- 1985-07-22 US US06/757,429 patent/US4692447A/en not_active Expired - Fee Related
- 1985-07-23 PT PT80854A patent/PT80854B/pt unknown
- 1985-07-26 NO NO852981A patent/NO852981L/no unknown
- 1985-07-26 ES ES545574A patent/ES8609274A1/es not_active Expired
- 1985-07-26 JP JP60166618A patent/JPS6147468A/ja active Pending
- 1985-07-26 KR KR1019850005362A patent/KR880000728B1/ko not_active Expired
- 1985-07-26 DD DD85279023A patent/DD238972A5/de not_active IP Right Cessation
- 1985-09-19 CN CN198585107017A patent/CN85107017A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ212721A (en) | 1989-01-06 |
| AU4481485A (en) | 1986-01-30 |
| GB2164643A (en) | 1986-03-26 |
| GB8419253D0 (en) | 1984-08-30 |
| KR880000728B1 (ko) | 1988-04-29 |
| FI852699A0 (fi) | 1985-07-08 |
| GR851722B (instruction) | 1985-11-26 |
| PT80854B (en) | 1987-01-09 |
| IL75864A0 (en) | 1985-11-29 |
| IL75864A (en) | 1990-07-26 |
| GB2164643B (en) | 1988-11-02 |
| US4692447A (en) | 1987-09-08 |
| AU576253B2 (en) | 1988-08-18 |
| EP0169443A2 (en) | 1986-01-29 |
| DK327685A (da) | 1986-01-28 |
| DK327685D0 (da) | 1985-07-18 |
| JPS6147468A (ja) | 1986-03-07 |
| HUT38915A (en) | 1986-07-28 |
| DD238972A5 (de) | 1986-09-10 |
| ZA855430B (en) | 1986-03-26 |
| FI852699A7 (fi) | 1986-01-28 |
| EP0169443A3 (en) | 1986-12-30 |
| KR860001076A (ko) | 1986-02-22 |
| ES545574A0 (es) | 1986-07-16 |
| FI852699L (fi) | 1986-01-28 |
| PT80854A (en) | 1985-08-01 |
| CN85107017A (zh) | 1987-04-01 |
| HU195193B (en) | 1988-04-28 |
| ES8609274A1 (es) | 1986-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO852981L (no) | Tricykliske dihydropyridazinoner og fremstilling derav. | |
| HU190703B (en) | Process for preparing new 1,2,3,4,4a,5,10,10a-octahydro-benzo/g/-quinoline derivatives | |
| NO831168L (no) | Nye derivater av cykloalka(c)pyrrol-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse samt nye cykloalka(c)pyrrol-karboksylsyrer som mellomtrinn og fremgangsmaate til deres fremst | |
| FR2665444A1 (fr) | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. | |
| CH624932A5 (instruction) | ||
| HU198030B (en) | Process for production of derivatives of benzotiasole and benzotiophen and medical preparatives containing these compounds as active substance | |
| DK171642B1 (da) | Anvendelse af trisubstituerede prolinderivater til fremstilling af tilsvarende carboxylsyrer og deres derivater | |
| JPS5811850B2 (ja) | １− オキソ −２，２− ジチカン −５− インダニロキシ （ マタハチオ ＃ アルカノイツクアシド | |
| US4247706A (en) | Dibenzothiepin derivatives and a process for producing the same | |
| DK149230B (da) | Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf | |
| US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
| HU178302B (en) | Process for producing n-amidino-3,5-diamino-6-substituted-2-piperazine-carboxamides | |
| US4057641A (en) | Method of treating inflammation with 2-(2,3-dihydro-2-isopropyl-4-oxo-4H-1-benzopyran-6-yl)propionic acid | |
| CA2424292A1 (en) | Tricyclic compounds and uses thereof | |
| EP1189903B1 (fr) | NOUVEAUX DERIVES DE LA BENZO[f]NAPHTYRIDINE, LEUR PREPARATION ET LES COMPOSITIONS LES CONTENANT | |
| US3663627A (en) | 1-indanmethanols | |
| NO178763B (no) | Fremgangsmåte for fremstilling av racemisk og optisk aktiv 1,2,3,4-tetrahydroisochinolin-3-karboksylsyre samt mellomprodukter derav | |
| JPH0246035B2 (instruction) | ||
| US4399145A (en) | Lactams Compositions and pharmaceutical methods of use | |
| US3678058A (en) | 1,3,4,9B-TETRAHYDRO-2(2H)-INDENO-{8 1,2-c{9 PYRIDINES | |
| US3843797A (en) | Saluretic and diuretic compositions and method with 2,3-dihydro-5-(2-nitro-1-alkenylbenzofuran-2-carboxylic acids and pharmaceutically acceptable salts | |
| US4775691A (en) | 4H-benzo[4,5]cyclohepta[1,2-b]thiophene derivatives | |
| US4291163A (en) | Decahydroquinoline-2-carboxylic acid compounds | |
| HU198928B (en) | Process for producing tetrahydro-beta-carboline derivatives and pharmaceutical compositions comprising same | |
| US3726904A (en) | 2,3-dihydro-5-(2-nitro-1-alkenyl)-benzofuran-2-carboxylic acid and pharmaceutically acceptable salts |